ArticleCancer gene therapy2015

The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy.

C R de Vries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.